Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anorexia Nervosa | 95 | 2023 | 1286 | 10.400 |
Why?
|
Human Growth Hormone | 38 | 2023 | 683 | 6.640 |
Why?
|
Bone Density | 69 | 2023 | 3468 | 4.360 |
Why?
|
Acromegaly | 16 | 2022 | 346 | 4.050 |
Why?
|
Body Composition | 62 | 2022 | 2402 | 3.570 |
Why?
|
Testosterone | 34 | 2023 | 2419 | 3.130 |
Why?
|
Insulin-Like Growth Factor I | 35 | 2023 | 2015 | 2.950 |
Why?
|
Hypopituitarism | 17 | 2023 | 254 | 2.810 |
Why?
|
Absorptiometry, Photon | 46 | 2023 | 1725 | 2.500 |
Why?
|
Overweight | 15 | 2023 | 2371 | 2.360 |
Why?
|
Amenorrhea | 18 | 2019 | 485 | 2.290 |
Why?
|
Androgens | 15 | 2019 | 1281 | 2.260 |
Why?
|
Hydrocortisone | 22 | 2023 | 1826 | 2.230 |
Why?
|
Obesity | 38 | 2023 | 12745 | 2.180 |
Why?
|
Premenopause | 15 | 2019 | 1033 | 2.130 |
Why?
|
Obesity, Abdominal | 6 | 2017 | 361 | 2.080 |
Why?
|
Pregnanolone | 3 | 2020 | 62 | 1.980 |
Why?
|
Hormone Replacement Therapy | 14 | 2019 | 745 | 1.950 |
Why?
|
Adipose Tissue | 26 | 2021 | 3280 | 1.800 |
Why?
|
Radius | 6 | 2021 | 422 | 1.530 |
Why?
|
Adrenal Insufficiency | 5 | 2021 | 184 | 1.440 |
Why?
|
Intra-Abdominal Fat | 11 | 2017 | 591 | 1.410 |
Why?
|
Dehydroepiandrosterone Sulfate | 6 | 2022 | 238 | 1.270 |
Why?
|
Endocrine System Diseases | 4 | 2016 | 248 | 1.270 |
Why?
|
Fasting | 7 | 2023 | 1592 | 1.250 |
Why?
|
Leptin | 20 | 2023 | 1600 | 1.230 |
Why?
|
Adiposity | 11 | 2018 | 1806 | 1.230 |
Why?
|
Hypothalamic Diseases | 9 | 2012 | 135 | 1.230 |
Why?
|
Bone Marrow | 9 | 2021 | 2948 | 1.220 |
Why?
|
Growth Hormone | 10 | 2023 | 705 | 1.200 |
Why?
|
Abdominal Fat | 3 | 2013 | 223 | 1.150 |
Why?
|
Contraceptives, Oral, Hormonal | 4 | 2019 | 188 | 1.130 |
Why?
|
Peptide YY | 9 | 2015 | 130 | 1.110 |
Why?
|
Bone and Bones | 24 | 2023 | 2576 | 1.100 |
Why?
|
Subcutaneous Fat, Abdominal | 2 | 2017 | 93 | 1.090 |
Why?
|
Oxytocin | 10 | 2023 | 394 | 1.070 |
Why?
|
Adult | 157 | 2024 | 214056 | 1.070 |
Why?
|
Body Mass Index | 44 | 2022 | 12720 | 1.030 |
Why?
|
Spine | 8 | 2023 | 1144 | 1.010 |
Why?
|
Cross-Sectional Studies | 54 | 2023 | 25041 | 1.000 |
Why?
|
Estrogens | 11 | 2022 | 1566 | 0.970 |
Why?
|
Thinness | 4 | 2017 | 480 | 0.970 |
Why?
|
Pituitary Neoplasms | 8 | 2023 | 1345 | 0.970 |
Why?
|
Bone Diseases, Metabolic | 10 | 2019 | 417 | 0.930 |
Why?
|
Cortisone | 1 | 2023 | 89 | 0.880 |
Why?
|
Estradiol | 22 | 2023 | 2020 | 0.870 |
Why?
|
Young Adult | 69 | 2024 | 56434 | 0.860 |
Why?
|
Tibia | 5 | 2022 | 1077 | 0.850 |
Why?
|
Bone Density Conservation Agents | 3 | 2022 | 772 | 0.820 |
Why?
|
Female | 199 | 2024 | 380200 | 0.820 |
Why?
|
Menstruation | 9 | 2019 | 302 | 0.810 |
Why?
|
Body Weight | 21 | 2017 | 4671 | 0.780 |
Why?
|
Adenoma | 6 | 2023 | 2174 | 0.740 |
Why?
|
Pelvic Bones | 2 | 2020 | 265 | 0.730 |
Why?
|
Receptors, Somatotropin | 2 | 2020 | 76 | 0.720 |
Why?
|
Hypothalamo-Hypophyseal System | 4 | 2019 | 703 | 0.710 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 3 | 2018 | 76 | 0.710 |
Why?
|
Bone Remodeling | 6 | 2022 | 575 | 0.700 |
Why?
|
Cushing Syndrome | 3 | 2016 | 249 | 0.700 |
Why?
|
Sex Hormone-Binding Globulin | 7 | 2016 | 548 | 0.690 |
Why?
|
Pituitary Diseases | 3 | 2016 | 141 | 0.690 |
Why?
|
Luteal Phase | 1 | 2019 | 147 | 0.680 |
Why?
|
Follicular Phase | 1 | 2019 | 153 | 0.680 |
Why?
|
Double-Blind Method | 19 | 2024 | 12025 | 0.670 |
Why?
|
Humans | 227 | 2024 | 744376 | 0.660 |
Why?
|
Middle Aged | 93 | 2024 | 213388 | 0.650 |
Why?
|
Etidronic Acid | 2 | 2011 | 64 | 0.640 |
Why?
|
Androstane-3,17-diol | 1 | 2017 | 19 | 0.630 |
Why?
|
Progesterone | 2 | 2019 | 775 | 0.620 |
Why?
|
Affective Symptoms | 2 | 2017 | 407 | 0.620 |
Why?
|
Lipid Metabolism Disorders | 1 | 2017 | 19 | 0.620 |
Why?
|
Growth Hormone-Releasing Hormone | 3 | 2009 | 213 | 0.610 |
Why?
|
Hip | 3 | 2017 | 257 | 0.610 |
Why?
|
Natriuretic Peptide, Brain | 5 | 2019 | 1572 | 0.610 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 2 | 2018 | 424 | 0.590 |
Why?
|
Regression Analysis | 20 | 2016 | 6459 | 0.540 |
Why?
|
Depressive Disorder, Major | 5 | 2020 | 4644 | 0.530 |
Why?
|
Adolescent | 87 | 2024 | 85784 | 0.530 |
Why?
|
Administration, Cutaneous | 7 | 2021 | 711 | 0.520 |
Why?
|
Peptide Fragments | 9 | 2019 | 5096 | 0.520 |
Why?
|
Pituitary-Adrenal System | 2 | 2016 | 553 | 0.520 |
Why?
|
Somatostatin | 4 | 2020 | 459 | 0.520 |
Why?
|
Hyperprolactinemia | 5 | 2016 | 129 | 0.510 |
Why?
|
Arginine | 2 | 2009 | 944 | 0.510 |
Why?
|
Appetite | 4 | 2019 | 243 | 0.500 |
Why?
|
Liver | 7 | 2024 | 7475 | 0.490 |
Why?
|
Anorexia | 1 | 2014 | 161 | 0.480 |
Why?
|
Liver Cirrhosis | 3 | 2024 | 1862 | 0.480 |
Why?
|
Insulin Resistance | 15 | 2020 | 3864 | 0.470 |
Why?
|
Anxiety | 5 | 2019 | 4296 | 0.460 |
Why?
|
Lumbar Vertebrae | 11 | 2023 | 1848 | 0.450 |
Why?
|
Diastole | 1 | 2015 | 791 | 0.450 |
Why?
|
Binge-Eating Disorder | 1 | 2015 | 137 | 0.450 |
Why?
|
Lipids | 6 | 2022 | 3307 | 0.440 |
Why?
|
Osteoporosis | 6 | 2012 | 1579 | 0.430 |
Why?
|
Glucagon | 1 | 2014 | 533 | 0.430 |
Why?
|
Reference Values | 14 | 2019 | 4982 | 0.420 |
Why?
|
Tomography, X-Ray Computed | 19 | 2019 | 20130 | 0.420 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2015 | 3759 | 0.410 |
Why?
|
Menopause | 2 | 2019 | 1626 | 0.410 |
Why?
|
Male | 78 | 2024 | 350118 | 0.390 |
Why?
|
Lipid Metabolism | 5 | 2018 | 1889 | 0.390 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2024 | 2214 | 0.380 |
Why?
|
Anthropometry | 6 | 2018 | 1350 | 0.380 |
Why?
|
Estrogen Replacement Therapy | 6 | 2021 | 1203 | 0.380 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2015 | 604 | 0.380 |
Why?
|
Radioimmunoassay | 5 | 2010 | 919 | 0.380 |
Why?
|
Cognition | 6 | 2016 | 6770 | 0.370 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2016 | 1953 | 0.370 |
Why?
|
Adipocytes | 1 | 2017 | 1185 | 0.360 |
Why?
|
Antidepressive Agents | 3 | 2020 | 2838 | 0.360 |
Why?
|
Depression | 8 | 2023 | 7766 | 0.360 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 11725 | 0.360 |
Why?
|
Finite Element Analysis | 5 | 2019 | 431 | 0.360 |
Why?
|
Athletes | 2 | 2019 | 1093 | 0.340 |
Why?
|
Case-Control Studies | 30 | 2021 | 21747 | 0.340 |
Why?
|
Cardiovascular Diseases | 13 | 2021 | 15159 | 0.340 |
Why?
|
Quality of Life | 10 | 2023 | 12803 | 0.330 |
Why?
|
Spinal Fractures | 1 | 2015 | 696 | 0.330 |
Why?
|
Carrier Proteins | 2 | 2019 | 5023 | 0.320 |
Why?
|
Triglycerides | 6 | 2010 | 2453 | 0.320 |
Why?
|
Prolactinoma | 3 | 2023 | 113 | 0.320 |
Why?
|
Pilot Projects | 9 | 2020 | 8319 | 0.320 |
Why?
|
Hip Fractures | 2 | 2014 | 955 | 0.320 |
Why?
|
Yoga | 2 | 2023 | 253 | 0.320 |
Why?
|
Placebos | 5 | 2017 | 1676 | 0.310 |
Why?
|
Gene Expression | 3 | 2021 | 7798 | 0.310 |
Why?
|
Hypogonadism | 4 | 2020 | 799 | 0.310 |
Why?
|
Bone Resorption | 2 | 2011 | 723 | 0.300 |
Why?
|
Liver Neoplasms | 2 | 2024 | 4253 | 0.300 |
Why?
|
Diabetes Insipidus, Neurogenic | 2 | 2020 | 19 | 0.300 |
Why?
|
Ghrelin | 12 | 2012 | 266 | 0.300 |
Why?
|
Adiponectin | 5 | 2010 | 1101 | 0.300 |
Why?
|
Weight-Bearing | 3 | 2019 | 515 | 0.290 |
Why?
|
Critical Illness | 1 | 2019 | 2670 | 0.280 |
Why?
|
Peptide Hormones | 7 | 2006 | 134 | 0.280 |
Why?
|
Depressive Disorder | 3 | 2016 | 3748 | 0.280 |
Why?
|
Erectile Dysfunction | 2 | 2020 | 461 | 0.270 |
Why?
|
Ergolines | 3 | 2017 | 61 | 0.270 |
Why?
|
Muscle, Skeletal | 6 | 2022 | 4925 | 0.270 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2009 | 555 | 0.270 |
Why?
|
Glucose | 7 | 2022 | 4398 | 0.270 |
Why?
|
Weight Gain | 8 | 2022 | 2293 | 0.270 |
Why?
|
Disease Management | 1 | 2016 | 2460 | 0.270 |
Why?
|
Sarcopenia | 2 | 2022 | 368 | 0.260 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3677 | 0.260 |
Why?
|
Brain Concussion | 3 | 2021 | 1320 | 0.250 |
Why?
|
Drug Therapy, Combination | 4 | 2021 | 6489 | 0.250 |
Why?
|
Amyloid | 1 | 2009 | 795 | 0.250 |
Why?
|
Subcutaneous Fat | 3 | 2017 | 391 | 0.250 |
Why?
|
Peptides, Cyclic | 2 | 2017 | 400 | 0.250 |
Why?
|
Dialysis | 1 | 2004 | 75 | 0.240 |
Why?
|
Football | 2 | 2020 | 460 | 0.240 |
Why?
|
Hormones | 8 | 2015 | 889 | 0.240 |
Why?
|
Growth Disorders | 1 | 2009 | 645 | 0.240 |
Why?
|
Aged | 25 | 2024 | 163284 | 0.230 |
Why?
|
Sex Characteristics | 5 | 2018 | 2585 | 0.230 |
Why?
|
Sexual Dysfunction, Physiological | 3 | 2016 | 360 | 0.230 |
Why?
|
Bromocriptine | 1 | 2023 | 111 | 0.220 |
Why?
|
Recombinant Proteins | 6 | 2021 | 6621 | 0.220 |
Why?
|
Follow-Up Studies | 14 | 2024 | 39052 | 0.220 |
Why?
|
Vitamin D | 4 | 2019 | 3224 | 0.220 |
Why?
|
Outpatients | 3 | 2011 | 1487 | 0.210 |
Why?
|
Obesity, Morbid | 1 | 2013 | 1213 | 0.210 |
Why?
|
Femur | 4 | 2014 | 1297 | 0.210 |
Why?
|
Body Fat Distribution | 2 | 2022 | 244 | 0.210 |
Why?
|
Nutrition Disorders | 1 | 2003 | 211 | 0.210 |
Why?
|
Nutritional Status | 8 | 2005 | 1609 | 0.210 |
Why?
|
Adrenocorticotropic Hormone | 2 | 2023 | 648 | 0.210 |
Why?
|
Gonadal Steroid Hormones | 5 | 2017 | 711 | 0.210 |
Why?
|
Feeding Behavior | 5 | 2019 | 3188 | 0.200 |
Why?
|
Cosyntropin | 1 | 2021 | 33 | 0.200 |
Why?
|
Nutrition Surveys | 3 | 2022 | 1660 | 0.200 |
Why?
|
Blood Glucose | 10 | 2022 | 6254 | 0.200 |
Why?
|
Exercise | 4 | 2013 | 5615 | 0.200 |
Why?
|
Diabetes Insipidus | 2 | 2019 | 151 | 0.200 |
Why?
|
HIV Wasting Syndrome | 2 | 1998 | 97 | 0.190 |
Why?
|
Thyrotoxicosis | 1 | 2001 | 82 | 0.190 |
Why?
|
Malnutrition | 2 | 2005 | 625 | 0.190 |
Why?
|
Thyroiditis | 1 | 2001 | 85 | 0.190 |
Why?
|
Osteogenesis | 3 | 2014 | 1299 | 0.190 |
Why?
|
Androstenedione | 1 | 2001 | 131 | 0.190 |
Why?
|
Lithium Carbonate | 1 | 2001 | 184 | 0.190 |
Why?
|
Sports | 4 | 2009 | 688 | 0.190 |
Why?
|
Treatment Outcome | 15 | 2023 | 63115 | 0.190 |
Why?
|
Appetite Regulation | 2 | 2019 | 88 | 0.190 |
Why?
|
Prevalence | 9 | 2022 | 15221 | 0.180 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2020 | 46 | 0.180 |
Why?
|
Natriuretic Peptides | 2 | 2011 | 150 | 0.180 |
Why?
|
Gyrus Cinguli | 3 | 2020 | 1091 | 0.180 |
Why?
|
Pituitary-Adrenal Function Tests | 1 | 2019 | 31 | 0.180 |
Why?
|
GABA Modulators | 1 | 2020 | 107 | 0.180 |
Why?
|
Globulins | 1 | 2019 | 19 | 0.180 |
Why?
|
Ethinyl Estradiol | 3 | 2005 | 116 | 0.180 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2017 | 6038 | 0.180 |
Why?
|
Bone Development | 2 | 2013 | 483 | 0.170 |
Why?
|
Adolescent Development | 2 | 2013 | 278 | 0.170 |
Why?
|
Abdomen | 2 | 2004 | 1118 | 0.170 |
Why?
|
Dopamine Agonists | 3 | 2014 | 355 | 0.170 |
Why?
|
Models, Biological | 1 | 2015 | 9584 | 0.170 |
Why?
|
Tumor Escape | 1 | 2021 | 350 | 0.160 |
Why?
|
Goserelin | 1 | 2019 | 129 | 0.160 |
Why?
|
Vasopressins | 1 | 2020 | 370 | 0.160 |
Why?
|
Calcium | 5 | 2023 | 5755 | 0.160 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2020 | 160 | 0.160 |
Why?
|
Fatty Liver | 1 | 2024 | 727 | 0.160 |
Why?
|
Femur Neck | 1 | 2019 | 309 | 0.150 |
Why?
|
Procollagen | 3 | 2014 | 185 | 0.150 |
Why?
|
C-Reactive Protein | 7 | 2013 | 3778 | 0.150 |
Why?
|
Postmenopause | 4 | 2020 | 2460 | 0.150 |
Why?
|
Antimanic Agents | 1 | 2001 | 522 | 0.150 |
Why?
|
Contraceptive Agents, Female | 2 | 2016 | 135 | 0.150 |
Why?
|
Contraceptives, Oral | 3 | 2011 | 564 | 0.150 |
Why?
|
Sensitivity and Specificity | 7 | 2019 | 14723 | 0.150 |
Why?
|
Retrospective Studies | 17 | 2021 | 77459 | 0.150 |
Why?
|
Protons | 3 | 2015 | 1127 | 0.140 |
Why?
|
HIV Protease Inhibitors | 2 | 1999 | 430 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10943 | 0.140 |
Why?
|
Endocrinology | 2 | 2014 | 443 | 0.140 |
Why?
|
Lipodystrophy | 1 | 2017 | 147 | 0.140 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 1 | 2016 | 45 | 0.140 |
Why?
|
Fractures, Bone | 3 | 2019 | 1947 | 0.140 |
Why?
|
Severity of Illness Index | 5 | 2019 | 15535 | 0.140 |
Why?
|
Calcium, Dietary | 1 | 2019 | 526 | 0.140 |
Why?
|
Time Factors | 8 | 2020 | 40077 | 0.140 |
Why?
|
Dyspareunia | 1 | 2016 | 50 | 0.140 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2018 | 300 | 0.130 |
Why?
|
Buttocks | 1 | 2016 | 110 | 0.130 |
Why?
|
Administration, Oral | 4 | 2019 | 3914 | 0.130 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 976 | 0.130 |
Why?
|
Oxytocics | 1 | 2016 | 68 | 0.130 |
Why?
|
Adrenal Gland Diseases | 1 | 2016 | 138 | 0.130 |
Why?
|
Treatment Failure | 2 | 2019 | 2618 | 0.130 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2016 | 129 | 0.130 |
Why?
|
Cell Size | 1 | 2017 | 643 | 0.130 |
Why?
|
Norgestrel | 2 | 2005 | 11 | 0.130 |
Why?
|
Cardiovascular System | 2 | 2013 | 831 | 0.130 |
Why?
|
Vaginal Diseases | 1 | 2016 | 102 | 0.130 |
Why?
|
Lipolysis | 1 | 2016 | 210 | 0.130 |
Why?
|
Waist-Hip Ratio | 1 | 2016 | 517 | 0.120 |
Why?
|
Adipokines | 1 | 2016 | 320 | 0.120 |
Why?
|
Apolipoproteins B | 2 | 2014 | 374 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1790 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2013 | 1677 | 0.120 |
Why?
|
Prognosis | 8 | 2021 | 29060 | 0.120 |
Why?
|
Lipase | 1 | 2016 | 314 | 0.120 |
Why?
|
Eating | 2 | 2019 | 1536 | 0.120 |
Why?
|
Child | 28 | 2023 | 77708 | 0.120 |
Why?
|
Polyuria | 1 | 2013 | 39 | 0.120 |
Why?
|
Hunger | 2 | 2019 | 198 | 0.110 |
Why?
|
Hot Temperature | 1 | 2019 | 1355 | 0.110 |
Why?
|
Osteocalcin | 1 | 2014 | 273 | 0.110 |
Why?
|
Tandem Mass Spectrometry | 1 | 2019 | 1157 | 0.110 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 547 | 0.110 |
Why?
|
Remission Induction | 3 | 2015 | 2386 | 0.110 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2015 | 175 | 0.110 |
Why?
|
Risk Factors | 15 | 2021 | 72295 | 0.110 |
Why?
|
Prednisone | 1 | 2017 | 1574 | 0.110 |
Why?
|
Dehydroepiandrosterone | 2 | 2016 | 252 | 0.110 |
Why?
|
Psychopathology | 3 | 2023 | 409 | 0.110 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2018 | 518 | 0.110 |
Why?
|
Extinction, Psychological | 1 | 2015 | 376 | 0.110 |
Why?
|
Golf | 1 | 2012 | 16 | 0.110 |
Why?
|
Down-Regulation | 3 | 2021 | 3001 | 0.110 |
Why?
|
Wrestling | 1 | 2012 | 18 | 0.110 |
Why?
|
Antipsychotic Agents | 2 | 2012 | 3057 | 0.110 |
Why?
|
Boston | 4 | 2016 | 9312 | 0.110 |
Why?
|
Atrial Natriuretic Factor | 1 | 2013 | 393 | 0.100 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 2 | 2009 | 123 | 0.100 |
Why?
|
Aspirin | 1 | 2024 | 3283 | 0.100 |
Why?
|
Health | 2 | 2012 | 394 | 0.100 |
Why?
|
Transdermal Patch | 1 | 2011 | 51 | 0.100 |
Why?
|
Impulsive Behavior | 1 | 2014 | 316 | 0.100 |
Why?
|
Affect | 4 | 2013 | 1475 | 0.100 |
Why?
|
Teriparatide | 1 | 2014 | 225 | 0.100 |
Why?
|
Follicle Stimulating Hormone, Human | 1 | 2011 | 25 | 0.100 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4933 | 0.100 |
Why?
|
Prolactin | 3 | 2010 | 669 | 0.100 |
Why?
|
Societies, Medical | 3 | 2014 | 3743 | 0.100 |
Why?
|
Comorbidity | 5 | 2021 | 10388 | 0.100 |
Why?
|
Risk Assessment | 3 | 2019 | 23336 | 0.100 |
Why?
|
Linear Models | 2 | 2012 | 5952 | 0.100 |
Why?
|
Saliva | 1 | 2015 | 809 | 0.100 |
Why?
|
Calcium-Transporting ATPases | 1 | 1991 | 123 | 0.100 |
Why?
|
Patient Selection | 3 | 2019 | 4216 | 0.100 |
Why?
|
Postprandial Period | 3 | 2019 | 292 | 0.100 |
Why?
|
Prospective Studies | 11 | 2023 | 53291 | 0.090 |
Why?
|
Vagina | 1 | 2016 | 825 | 0.090 |
Why?
|
Dacarbazine | 1 | 2013 | 566 | 0.090 |
Why?
|
Area Under Curve | 3 | 2009 | 1655 | 0.090 |
Why?
|
Islet Amyloid Polypeptide | 1 | 2009 | 41 | 0.090 |
Why?
|
Personality Inventory | 2 | 2019 | 1030 | 0.090 |
Why?
|
Thyrotropin | 1 | 2013 | 849 | 0.090 |
Why?
|
Analysis of Variance | 4 | 2011 | 6366 | 0.090 |
Why?
|
Body Dysmorphic Disorders | 1 | 2013 | 229 | 0.090 |
Why?
|
Women's Health | 2 | 2016 | 2034 | 0.090 |
Why?
|
Chronic Disease | 2 | 2022 | 9145 | 0.090 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1343 | 0.090 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2009 | 357 | 0.090 |
Why?
|
Mental Disorders | 3 | 2022 | 6600 | 0.090 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2013 | 627 | 0.090 |
Why?
|
Exercise Test | 2 | 2018 | 2073 | 0.080 |
Why?
|
Dietary Fats | 3 | 2009 | 2016 | 0.080 |
Why?
|
Skinfold Thickness | 1 | 2008 | 162 | 0.080 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2008 | 45 | 0.080 |
Why?
|
Interferon-beta | 1 | 2010 | 324 | 0.080 |
Why?
|
Reproduction | 1 | 2013 | 668 | 0.080 |
Why?
|
Luteinizing Hormone | 1 | 2011 | 869 | 0.080 |
Why?
|
RNA, Messenger | 2 | 2016 | 13035 | 0.080 |
Why?
|
Hypertension | 2 | 2022 | 8479 | 0.080 |
Why?
|
Hip Joint | 2 | 2013 | 1002 | 0.080 |
Why?
|
Trabecular Meshwork | 1 | 2008 | 99 | 0.080 |
Why?
|
Single-Blind Method | 1 | 2012 | 1591 | 0.080 |
Why?
|
Circadian Rhythm | 3 | 2015 | 2624 | 0.080 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2016 | 3480 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8642 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4554 | 0.080 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2009 | 1159 | 0.080 |
Why?
|
Reproducibility of Results | 6 | 2016 | 19905 | 0.070 |
Why?
|
Heart Valves | 1 | 2009 | 291 | 0.070 |
Why?
|
Body Height | 3 | 2008 | 1578 | 0.070 |
Why?
|
Running | 1 | 2012 | 480 | 0.070 |
Why?
|
Sodium | 1 | 2012 | 1622 | 0.070 |
Why?
|
Executive Function | 1 | 2016 | 1364 | 0.070 |
Why?
|
Fear | 1 | 2015 | 1440 | 0.070 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2012 | 838 | 0.070 |
Why?
|
Dietary Carbohydrates | 2 | 2009 | 905 | 0.070 |
Why?
|
ROC Curve | 3 | 2011 | 3527 | 0.070 |
Why?
|
Longitudinal Studies | 6 | 2022 | 13988 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3873 | 0.070 |
Why?
|
Universities | 1 | 2012 | 956 | 0.070 |
Why?
|
Psychotropic Drugs | 1 | 2012 | 894 | 0.070 |
Why?
|
Age Factors | 3 | 2019 | 18373 | 0.070 |
Why?
|
Insulin | 8 | 2010 | 6582 | 0.070 |
Why?
|
Proteins | 3 | 2014 | 6100 | 0.070 |
Why?
|
Neurotic Disorders | 1 | 2006 | 79 | 0.070 |
Why?
|
Sexual Behavior | 3 | 2016 | 2055 | 0.070 |
Why?
|
United States | 5 | 2022 | 69869 | 0.070 |
Why?
|
Contraceptives, Oral, Synthetic | 1 | 2005 | 16 | 0.070 |
Why?
|
Memory | 1 | 2016 | 2174 | 0.070 |
Why?
|
Massachusetts | 4 | 2012 | 8662 | 0.070 |
Why?
|
Computer Simulation | 1 | 2019 | 6194 | 0.070 |
Why?
|
Anxiety Disorders | 2 | 2016 | 2690 | 0.070 |
Why?
|
Bone Diseases | 1 | 2009 | 416 | 0.070 |
Why?
|
Drug Synergism | 1 | 2009 | 1797 | 0.070 |
Why?
|
Oxygen Consumption | 1 | 2012 | 1868 | 0.060 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2007 | 370 | 0.060 |
Why?
|
Petrosal Sinus Sampling | 1 | 2004 | 23 | 0.060 |
Why?
|
Sex Factors | 3 | 2018 | 10400 | 0.060 |
Why?
|
Waist Circumference | 1 | 2008 | 917 | 0.060 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2010 | 857 | 0.060 |
Why?
|
Endoplasmic Reticulum | 1 | 1991 | 1146 | 0.060 |
Why?
|
Leg | 1 | 2010 | 1116 | 0.060 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2008 | 450 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2013 | 7882 | 0.060 |
Why?
|
Norethindrone | 1 | 2004 | 59 | 0.060 |
Why?
|
RNA Interference | 1 | 2013 | 2891 | 0.060 |
Why?
|
Attitude to Health | 1 | 2013 | 2052 | 0.060 |
Why?
|
Triiodothyronine | 2 | 2005 | 494 | 0.060 |
Why?
|
Brain | 3 | 2015 | 26386 | 0.060 |
Why?
|
Collagen Type I | 3 | 2013 | 592 | 0.060 |
Why?
|
Dietary Proteins | 1 | 2009 | 963 | 0.060 |
Why?
|
Fibroblast Growth Factors | 1 | 2009 | 878 | 0.060 |
Why?
|
Drug Resistance | 1 | 2009 | 1608 | 0.060 |
Why?
|
Cholesterol, HDL | 2 | 2008 | 1813 | 0.060 |
Why?
|
Brain Injuries | 1 | 2015 | 2029 | 0.060 |
Why?
|
Water | 1 | 2010 | 1395 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2008 | 15078 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9240 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 6 | 2020 | 35424 | 0.060 |
Why?
|
Blood Chemical Analysis | 1 | 2005 | 440 | 0.060 |
Why?
|
Lower Extremity | 1 | 2011 | 1158 | 0.050 |
Why?
|
Bradycardia | 1 | 2004 | 307 | 0.050 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 6994 | 0.050 |
Why?
|
Practice Guidelines as Topic | 3 | 2016 | 7281 | 0.050 |
Why?
|
Postoperative Period | 2 | 2020 | 1842 | 0.050 |
Why?
|
Basal Metabolism | 2 | 2006 | 168 | 0.050 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2003 | 113 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 1998 | 4255 | 0.050 |
Why?
|
Malabsorption Syndromes | 1 | 2003 | 135 | 0.050 |
Why?
|
Fluoxetine | 1 | 2006 | 749 | 0.050 |
Why?
|
Students | 1 | 2012 | 1651 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10259 | 0.050 |
Why?
|
Nutrition Assessment | 2 | 2004 | 723 | 0.050 |
Why?
|
Space Perception | 1 | 2004 | 475 | 0.050 |
Why?
|
Menstrual Cycle | 2 | 2004 | 551 | 0.050 |
Why?
|
Pregnancy | 1 | 2023 | 29144 | 0.050 |
Why?
|
Radiography | 1 | 2012 | 7023 | 0.050 |
Why?
|
Self Concept | 1 | 2007 | 1025 | 0.050 |
Why?
|
Deficiency Diseases | 1 | 2001 | 72 | 0.050 |
Why?
|
Up-Regulation | 3 | 2021 | 4222 | 0.050 |
Why?
|
Libido | 1 | 2001 | 121 | 0.050 |
Why?
|
Social Behavior | 1 | 2007 | 1127 | 0.050 |
Why?
|
Adolescent Behavior | 1 | 2009 | 1151 | 0.050 |
Why?
|
Glucose Tolerance Test | 3 | 2010 | 1150 | 0.050 |
Why?
|
Cohort Studies | 2 | 2021 | 40558 | 0.050 |
Why?
|
Mitochondria | 1 | 2013 | 3514 | 0.050 |
Why?
|
Arousal | 1 | 2006 | 1164 | 0.040 |
Why?
|
Cholesterol | 3 | 2008 | 2919 | 0.040 |
Why?
|
End Stage Liver Disease | 1 | 2024 | 314 | 0.040 |
Why?
|
Graves Disease | 1 | 2001 | 242 | 0.040 |
Why?
|
Muscles | 3 | 2014 | 1614 | 0.040 |
Why?
|
Interpersonal Relations | 1 | 2007 | 1425 | 0.040 |
Why?
|
Homeostasis | 1 | 2010 | 3339 | 0.040 |
Why?
|
Satiation | 1 | 2019 | 80 | 0.040 |
Why?
|
Arginine Vasopressin | 1 | 2019 | 130 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2006 | 6234 | 0.040 |
Why?
|
Aging | 2 | 2016 | 8663 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 871 | 0.040 |
Why?
|
Heart Ventricles | 1 | 2010 | 3817 | 0.040 |
Why?
|
Iodine Radioisotopes | 1 | 2001 | 1032 | 0.040 |
Why?
|
Thyroxine | 1 | 2001 | 667 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 7914 | 0.040 |
Why?
|
Ovulation | 1 | 1998 | 189 | 0.040 |
Why?
|
E-Selectin | 2 | 2010 | 579 | 0.040 |
Why?
|
Administration, Topical | 1 | 2019 | 690 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3751 | 0.040 |
Why?
|
Emotions | 1 | 2009 | 2658 | 0.040 |
Why?
|
Endocrine Glands | 1 | 1997 | 103 | 0.040 |
Why?
|
Diagnostic Errors | 1 | 2004 | 1257 | 0.040 |
Why?
|
Pituitary Hormones | 2 | 2010 | 183 | 0.040 |
Why?
|
Pituitary Gland | 2 | 2013 | 665 | 0.040 |
Why?
|
Calcium-Binding Proteins | 2 | 2013 | 1081 | 0.040 |
Why?
|
Interleukin-6 | 4 | 2009 | 3203 | 0.040 |
Why?
|
Lipoprotein(a) | 1 | 2000 | 435 | 0.030 |
Why?
|
Brain Hemorrhage, Traumatic | 1 | 2015 | 18 | 0.030 |
Why?
|
Orgasm | 1 | 2016 | 64 | 0.030 |
Why?
|
Vaginal Creams, Foams, and Jellies | 1 | 2016 | 63 | 0.030 |
Why?
|
Hyperinsulinism | 1 | 1999 | 415 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1531 | 0.030 |
Why?
|
Administration, Intravaginal | 1 | 2016 | 150 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 2010 | 3079 | 0.030 |
Why?
|
Inflammation | 2 | 2014 | 10636 | 0.030 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2016 | 170 | 0.030 |
Why?
|
Glycoproteins | 1 | 2003 | 2266 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 2019 | 490 | 0.030 |
Why?
|
Cerebral Cortex | 2 | 2015 | 5709 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13695 | 0.030 |
Why?
|
HIV Infections | 2 | 1998 | 16715 | 0.030 |
Why?
|
Evidence-Based Medicine | 3 | 2014 | 3610 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 12073 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2004 | 2866 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2001 | 1173 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2021 | 57776 | 0.030 |
Why?
|
Avoidance Learning | 1 | 2015 | 233 | 0.030 |
Why?
|
Prefrontal Cortex | 1 | 2004 | 2147 | 0.030 |
Why?
|
Pituitary Gland, Posterior | 1 | 2013 | 43 | 0.030 |
Why?
|
Thorax | 2 | 2008 | 547 | 0.030 |
Why?
|
Statistics as Topic | 2 | 2012 | 2373 | 0.030 |
Why?
|
Chemical Phenomena | 1 | 2013 | 518 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2016 | 3529 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2015 | 5077 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2008 | 14561 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 956 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 968 | 0.030 |
Why?
|
Calorimetry, Indirect | 2 | 2006 | 183 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 7730 | 0.030 |
Why?
|
Trace Elements | 2 | 2006 | 198 | 0.030 |
Why?
|
Puberty | 2 | 2007 | 490 | 0.030 |
Why?
|
Porosity | 1 | 2013 | 362 | 0.030 |
Why?
|
Cyclic GMP | 1 | 2013 | 409 | 0.030 |
Why?
|
Organ Size | 2 | 2010 | 2251 | 0.030 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2016 | 370 | 0.030 |
Why?
|
Schizophrenia | 1 | 2010 | 6882 | 0.030 |
Why?
|
Data Interpretation, Statistical | 2 | 2013 | 2716 | 0.020 |
Why?
|
Calcium Radioisotopes | 1 | 1991 | 9 | 0.020 |
Why?
|
Diet | 1 | 2009 | 7937 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2013 | 513 | 0.020 |
Why?
|
COS Cells | 1 | 2013 | 1161 | 0.020 |
Why?
|
Sodium Chloride, Dietary | 1 | 2013 | 281 | 0.020 |
Why?
|
Psychometrics | 2 | 2014 | 3002 | 0.020 |
Why?
|
Risk | 2 | 2014 | 9688 | 0.020 |
Why?
|
Extremities | 2 | 2008 | 866 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1524 | 0.020 |
Why?
|
Hypothyroidism | 1 | 2015 | 658 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1999 | 2232 | 0.020 |
Why?
|
Menarche | 2 | 2004 | 516 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 2015 | 819 | 0.020 |
Why?
|
Histocytochemistry | 1 | 1991 | 719 | 0.020 |
Why?
|
Hyponatremia | 1 | 2012 | 298 | 0.020 |
Why?
|
Dopamine Antagonists | 1 | 2010 | 296 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1991 | 2186 | 0.020 |
Why?
|
Mental Recall | 1 | 2015 | 1206 | 0.020 |
Why?
|
Satiety Response | 1 | 2009 | 49 | 0.020 |
Why?
|
Causality | 1 | 2016 | 1275 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2016 | 828 | 0.020 |
Why?
|
Energy Intake | 3 | 2006 | 2148 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 1991 | 1375 | 0.020 |
Why?
|
Peptides | 2 | 2013 | 4410 | 0.020 |
Why?
|
Blotting, Northern | 1 | 1991 | 1581 | 0.020 |
Why?
|
Hormone Antagonists | 1 | 2009 | 108 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2013 | 8949 | 0.020 |
Why?
|
Fats | 1 | 2009 | 102 | 0.020 |
Why?
|
Astrocytoma | 1 | 2013 | 790 | 0.020 |
Why?
|
Sexual Development | 1 | 2008 | 34 | 0.020 |
Why?
|
Acylation | 1 | 2008 | 107 | 0.020 |
Why?
|
Risperidone | 1 | 2010 | 383 | 0.020 |
Why?
|
Disabled Persons | 1 | 2018 | 1212 | 0.020 |
Why?
|
Thyroid Hormones | 1 | 2010 | 390 | 0.020 |
Why?
|
Amygdala | 1 | 2015 | 1315 | 0.020 |
Why?
|
Immunoassay | 1 | 2011 | 752 | 0.020 |
Why?
|
Cluster Analysis | 2 | 2005 | 2715 | 0.020 |
Why?
|
Gonadotropins | 1 | 2008 | 241 | 0.020 |
Why?
|
Echocardiography | 2 | 2010 | 5099 | 0.020 |
Why?
|
Growth Plate | 1 | 2008 | 274 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3587 | 0.020 |
Why?
|
Brain Neoplasms | 2 | 2013 | 8862 | 0.020 |
Why?
|
Drug Utilization | 1 | 2012 | 1183 | 0.020 |
Why?
|
Body Image | 1 | 2010 | 610 | 0.020 |
Why?
|
Genetic Markers | 1 | 2012 | 2634 | 0.020 |
Why?
|
Growth | 1 | 2007 | 376 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8091 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2016 | 2002 | 0.020 |
Why?
|
Health Status | 1 | 2018 | 4033 | 0.020 |
Why?
|
Diet Records | 1 | 2006 | 425 | 0.020 |
Why?
|
Differential Threshold | 1 | 2004 | 80 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13285 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2011 | 1405 | 0.020 |
Why?
|
Ovary | 1 | 2009 | 981 | 0.020 |
Why?
|
Dominance, Cerebral | 1 | 2006 | 635 | 0.020 |
Why?
|
Age Determination by Skeleton | 1 | 2004 | 129 | 0.020 |
Why?
|
Hematocrit | 1 | 2005 | 636 | 0.010 |
Why?
|
Occipital Lobe | 1 | 2006 | 379 | 0.010 |
Why?
|
Lipoproteins, LDL | 1 | 2007 | 640 | 0.010 |
Why?
|
Pulsatile Flow | 1 | 2005 | 332 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2703 | 0.010 |
Why?
|
Steroids | 1 | 2009 | 930 | 0.010 |
Why?
|
Hematologic Tests | 1 | 2004 | 240 | 0.010 |
Why?
|
Periodicity | 1 | 2005 | 364 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8340 | 0.010 |
Why?
|
False Negative Reactions | 1 | 2004 | 588 | 0.010 |
Why?
|
Animals | 3 | 2013 | 168770 | 0.010 |
Why?
|
Lipoproteins | 1 | 2008 | 878 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3557 | 0.010 |
Why?
|
Lipoproteins, HDL | 1 | 2007 | 638 | 0.010 |
Why?
|
Seizures | 1 | 2015 | 2859 | 0.010 |
Why?
|
Osteoprotegerin | 1 | 2003 | 176 | 0.010 |
Why?
|
Receptors, Leptin | 1 | 2004 | 361 | 0.010 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2004 | 369 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2012 | 1637 | 0.010 |
Why?
|
Mesenchymal Stem Cells | 1 | 2013 | 1632 | 0.010 |
Why?
|
Solubility | 1 | 2004 | 1088 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16367 | 0.010 |
Why?
|
Equipment Design | 1 | 2011 | 3582 | 0.010 |
Why?
|
Dietary Fiber | 1 | 2006 | 760 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2887 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4805 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 2918 | 0.010 |
Why?
|
Mice | 1 | 2008 | 81202 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2003 | 595 | 0.010 |
Why?
|
Energy Metabolism | 2 | 2006 | 2897 | 0.010 |
Why?
|
Potassium | 1 | 2004 | 1336 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4042 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2006 | 1406 | 0.010 |
Why?
|
Drug Combinations | 1 | 2004 | 1958 | 0.010 |
Why?
|
Nutritional Requirements | 1 | 2000 | 286 | 0.010 |
Why?
|
Phosphates | 1 | 2002 | 785 | 0.010 |
Why?
|
Temporal Lobe | 1 | 2006 | 1670 | 0.010 |
Why?
|
Vitamins | 1 | 2006 | 1623 | 0.010 |
Why?
|
Stroke Volume | 1 | 2010 | 5006 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2006 | 2016 | 0.010 |
Why?
|
Mass Screening | 1 | 2012 | 5255 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2006 | 2050 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23406 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11486 | 0.010 |
Why?
|
Mutation | 1 | 2020 | 29786 | 0.010 |
Why?
|
Electric Impedance | 1 | 1998 | 729 | 0.010 |
Why?
|
Rats | 1 | 1991 | 24252 | 0.010 |
Why?
|
Recovery of Function | 1 | 2004 | 2926 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 15520 | 0.010 |
Why?
|
Heart Rate | 1 | 2004 | 4091 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 20950 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2001 | 2355 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12244 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 13882 | 0.010 |
Why?
|
Blood Pressure | 1 | 2004 | 8551 | 0.010 |
Why?
|